Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Tiotropium best at cutting COPD exacerbations

Tiotropium reduces the risk of exacerbations and hospitalisations compared with combined ipratropium/salbutamol in patients with COPD, a UK study concludes.

The researchers analysed data on 4,193 patients on the UK general practice research database, 3,385 of them on tiotropium and 808 of them on ipratropium/salbutamol.

After controlling for the severity of illness, treatment with tiotropium reduced the risk of an exacerbation by 26% and the risk of COPD-related referrals and hospitalisations by 43%.

Primary Care Respiratory Journal 2008 2 April early online publication

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say